Your search history is turned on.
Date: April 19, 2024 Jurisdictions: British Columbia
1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, DONALD GORDON, CHIEF FINANCIAL OFFICER OF MUSIRUM HEALTH SCIENCE INC., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of MUSIRUM HEALTH SCIENCE INC. (the issuer) for the interim period end...
1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, DONALD GORDON, CHIEF EXECUTIVE OFFICER OF MUSIRUM HEALTH SCIENCE INC., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of MUSIRUM HEALTH SCIENCE INC. (the issuer) for the interim period end...
1 MUSIRUM HEALTH SCIENCE INC. MANAGEMENTS DISCUSSION & ANALYSIS For the nine months ended February 29, 2024 and February 28, 2023 (Expressed in Canadian dollars) 2 MUSIRUM HEALTH SCIENCE INC. Management Discussion and Analysis ...
MUSIRUM HEALTH SCIENCE INC. INTERIM FINANCIAL STATEMENTS For the Nine Months Ended February 29, 2024 and February 28, 2022 Unaudited (Expressed in Canadian Dollars) Notice of No Auditor Review of Interim Financial Statements The acco...
1 MUSIRUM HEALTH SCIENCE INC. MANAGEMENTS DISCUSSION & ANALYSIS For the six months ended November 30, 2023 and 2022 (Expressed in Canadian dollars) 2 MUSIRUM HEALTH SCIENCE INC. Management Discussion and Analysis For the six...
MUSIRUM HEALTH SCIENCE INC. INTERIM FINANCIAL STATEMENTS For the Six Months Ended November 30, 2023 and 2022 Unaudited (Expressed in Canadian Dollars) Notice of No Auditor Review of Interim Financial Statements The accompanying una...